Medical Marijuana Edibles:
SB 512 revises Florida’s medical marijuana law to tighten and standardize packaging and labeling rules for medical marijuana edibles and related products. The bill adds detailed requirements for edible products, including plain, opaque packaging; child-resistant and child-deterring presentation; limits on THC content per edible and per serving; restrictions on shapes, colors, and branding that could appeal to children; and mandatory labeling and insert information covering ingredients, allergens, storage, expiration, warnings, and product identity. It also directs the Department of Health to adopt rules governing allowed and prohibited edible shapes, forms, ingredients, and sanitation standards before edibles may be processed or dispensed.
Beyond edibles, the bill amends the broader medical marijuana treatment center framework in section 381.986, Florida Statutes, by restating and reinforcing existing operational, testing, packaging, dispensing, and recordkeeping requirements. These include food safety permitting for edible producers, testing and recall obligations, packaging rules for smoking products, limits on dispensing quantities, registry verification requirements, and restrictions on sales of non-medical cannabis-related products. The bill’s effective date is July 1, 2025.
SB 512 would amend s. 381.986, F.S., the core statute governing Florida’s medical marijuana treatment centers, by imposing more specific packaging, labeling, and product-design standards for edibles and by reinforcing related compliance obligations for licensed operators. It would require the Department of Health to adopt additional rules on edible appearance, ingredients, and sanitation, and would tie edible production to food-establishment permitting under chapter 500. The bill primarily affects medical marijuana treatment centers, their processors and dispensers, and the Department of Health, while also implicating the Department of Agriculture and Consumer Services and the Department of Environmental Protection in rule development and oversight.
The available legislative history suggests the bill did not advance, as it died in the Senate Health Policy Committee on June 16, 2025. With no recorded votes or committee transcript excerpts provided, the public record here does not show detailed debate or amendments. The bill’s content indicates a regulatory and child-safety oriented approach, which is generally consistent with a cautious or restrictive posture toward medical marijuana edibles rather than expansion of access.
The main points of contention likely center on how far the state should go in restricting edible product design and packaging, and whether the rules are too burdensome for medical marijuana treatment centers. Specific issues include bans on child-attractive shapes and colors, limits on THC potency, plain packaging requirements, mandatory food-safety compliance, and the requirement that edibles not begin processing or dispensing until department rules are in place. Industry stakeholders may view these provisions as costly or operationally restrictive, while regulators and child-safety advocates would likely support them as necessary to reduce accidental ingestion and improve product safety.